Bristol-Myers Squibb buy BiotechBee
Start price
07.09.22
/
70%
€69.37
Target price
31.12.25
€100.00
Performance (%)
-12.07%
End price
05.05.23
€61.00
Summary
This prediction ended on 05.05.23 with a price of €61.00. The prediction for Bristol-Myers Squibb disappointed with a performance of -12.07%. A total of €1.61 was paid as dividends for this prediction. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Bristol-Myers Squibb | -2.493% | -2.493% | -33.859% |
| iShares Core DAX® | -0.922% | -1.078% | 12.165% |
| iShares Nasdaq 100 | 0.371% | -0.556% | 38.622% |
| iShares Nikkei 225® | 2.224% | -2.825% | 19.015% |
| iShares S&P 500 | -0.026% | -0.788% | 28.485% |
According to BiotechBee what are the pros and cons of Bristol-Myers Squibb for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Bristol-Myers Squibb diskutieren
Buy mit Kursziel 100,0